BeiGene
BGNE
#926
Rank
NZ$36.42 B
Marketcap
$325.45
Share price
-2.08%
Change (1 day)
6.58%
Change (1 year)
BeiGene is a Chinese pharmaceutical company engaged in the R&D, and commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

Stock price history for BeiGene (BGNE)

Highest end of day price: $688.68 NZD on 2021-09-17

Lowest end of day price: $40.97 NZD on 2016-02-12

Stock price history of BeiGene from 2016 to 2024

Stock price for similar companies or competitors

Company Stock price Change 1d% Country
$1.70-0.47%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.70 1.28%๐Ÿ‡บ๐Ÿ‡ธ USA